Key design considerations on comparative clinical efficacy studies for biosimilars: adalimumab as an example. [electronic resource]
Producer: 20160212Description: e000154 p. digitalISSN:- 2056-5933
No physical items for this record
Publication Type: Journal Article; Review
There are no comments on this title.
Log in to your account to post a comment.